APA

Tabarroki A., Saunthararajah Y., Visconte V., Cinalli T., Colaluca K., Rogers H. J., Sekeres M. A., Duong H. K., Stein B. L. & Tiu R. V. (20160405). Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. : Leukemia & lymphoma.

Chicago

Tabarroki Ali, Saunthararajah Yogen, Visconte Valeria, Cinalli Tracy, Colaluca Kristin, Rogers Heesun J, Sekeres Mikkael A, Duong Hien K, Stein Brady L and Tiu Ramon V. 20160405. Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. : Leukemia & lymphoma.

Harvard

Tabarroki A., Saunthararajah Y., Visconte V., Cinalli T., Colaluca K., Rogers H. J., Sekeres M. A., Duong H. K., Stein B. L. and Tiu R. V. (20160405). Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. : Leukemia & lymphoma.

MLA

Tabarroki Ali, Saunthararajah Yogen, Visconte Valeria, Cinalli Tracy, Colaluca Kristin, Rogers Heesun J, Sekeres Mikkael A, Duong Hien K, Stein Brady L and Tiu Ramon V. Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. : Leukemia & lymphoma. 20160405.